Stocks To Buy Now Blog

All posts by Christopher

OriginClear Inc. (OCLN) CEO Calls Recycling Water Worldwide Issue; Company Leads Decentralization Efforts

  • Increased pollution, rising population and climate change all straining worldwide water supply
  • Biggest issue that keeps U.S., other countries from success is reliance on centralized water technologies
  • Infrastructure failure can be addressed by developing decentralized, onsite and modular water-treatment systems like OriginClear Inc.’s innovative products

Recycling water is a worldwide issue, according to OriginClear Inc. (OTC: OCLN) CEO Riggs Eckelberry, who noted that with issues such as increased pollution, rising population and climate change all straining worldwide water supply, poor levels of water recycling are not sustainable.

“Leaders across all industries need to rethink their entire approach to using and delivering water,” Eckelberry noted in a recent article (http://ibn.fm/0BXVG) titled ‘Israel Recycles 90 Percent of Its Water, the U.S. Recycles 1 Percent. Here’s How We Can Change That’.

In the article, Eckelberry described the varying levels of water advancement found in countries around the globe. He referenced the lack of consistency in countries industrial advancements, especially regarding water technology. Achieving a level of 90% water recycling, Israel is the world leader by far; Spain ranks second at only 20%. Alarmingly, America lags behind at a mere 1%.

OriginClear is on a mission to change those numbers, seeing tremendous potential in the future of water management around the world.

“The biggest issue that keeps the United States and other areas of the world from reaching Israel’s exceptional level of success is the reliance on centralized water technologies,” Eckelberry said. “An estimated 90% of people in the United States rely on mega-facilities for water treatment and distribution, both for home and business use. That means that, to a large degree, people have very little control over their water.”

Complicating the matter is the fact that those facilities are breaking down, Eckelberry explained. Unfortunately, “maintaining and repairing them balloons the already unnecessarily high price tag of moving water from one place to another safely. And increasingly, it’s just not economically viable to keep the facilities open at all.”

The good news is that the infrastructure failure can be addressed by developing and using decentralized, onsite and modular water-treatment systems, said Eckelberry. “These systems can scale based on personal, business or community needs. They also can be built flexibly in ways that address specific geographical concerns or advantages.”

OriginClear is leading the way to water decentralization. A leading provider of these types of water-treatment solutions, OriginClear offers breakthrough water-treatment and conveyance products that can effectively improve the quality of water around the world by returning it to its original and clear condition. The company’s stated mission is to empower this global movement with modular water-treatment and conveyance products that enable water independence and help make clean water available globally.

For more information, visit the company’s website at www.OriginClear.com

NOTE TO INVESTORS: The latest news and updates relating to OCLN are available in the company’s newsroom at http://ibn.fm/OCLN

ChineseInvestors.com Inc. (CIIX) Offers Powerful Two-Pronged Strategy for Investors, Shows Promise in China’s Emerging CBD Sector

  • ChineseInvestors.com has become top financial-information website
  • The company is also advancing its cannabidiol program
  • CIIX offers investors multiple revenue streams, healthy return potential

Based in San Gabriel, California, ChineseInvestors.com Inc. (OTCQB: CIIX) offers a proprietary financial-news media and content platform. The company has become a foremost financial-information website for Chinese-speaking investors in the United States and China. Via its main website – www.ChineseInvestors.com – CIIX offers an array of investor-education products and services. CIIX is also laying the foundation to capitalize on increasing demand for CBD (cannabidiol)-based nutrition and health products.

CIIX’s investor-education products and services include real-time market commentary, analysis and educational-related services in Chinese-language character sets. The company also provides consultative services to smaller private companies considering becoming public, as well as advertising and public-relations-related support services.

As a core element of its services, CIIX features its exclusive ChineseInvestors Method, an innovative integration of a disciplined investing process, web-based tools, personalized instructions and invaluable support. With this strategy, the company provides reliable market information to assist investors in making informed investment decisions and meeting their individual financial goals.

CIIX raises investor awareness through investor conferences and road shows. The company has a subscriber base of free and paying members, with its base membership – 95% – primarily located in the United States and Canada. CIIX services are largely delivered to U.S. public and private companies and U.S. residents and citizens. The company delivers its services in both traditional and simplified Chinese-language character sets (http://ibn.fm/wFVFL).

CIIX’s CBD initiatives are carried out by its subsidiary, CBD Biotech Inc. In essence, CIIX is taking advantage of its own financial expertise to establish itself as a leader in China’s developing CBD industry. Through CBD Biotech, CIIX has established a three-year development plan to capitalize on the union of CBD and the nutrition and health products market in mainland China.

Subsequent to entering into a wholesale agreement with a well-known CBD health brand in December 2016, CIIX formally launched the website ChineseCBDOil.com (http://ibn.fm/dtgJL). This website is one of the world’s first online stores in the Chinese language, providing industrial-hemp-derived CBD products for Chinese-speaking customers around the world. Products available on the site include soft gels, capsules and concentrates. In addition, CIIX opened a retail store in San Gabriel, California, which has a high Chinese population.

Of note to investors is that CIIX CEO Warren Wang has said the company is planning an IPO of wholly owned CBD Biotech. In the announcement, Wang noted that CIIX hopes for a Nasdaq IPO of CBD Biotech early in 2020. CIIX would then concentrate on identifying an acquisition target for further growth (http://ibn.fm/I1iRR).

CIIX continues to focus on providing premier financial information via its main website. At the same time, the company is leveraging the opportunity for significant revenue streams through its CBD Biotech subsidiary. For investors, CIIX offers a two-pronged business strategy for a healthy return on investment.

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX

Sigma Labs Inc. (NASDAQ: SGLB) to Help Aerospace Manufacturers Overcome 3D Quality Manufacturing Problems

  • 3D-printed weight-optimized and flow-optimized parts significantly improve the performance of aircraft and rockets
  • Global aerospace 3D-printing market estimated at $1.4 billion in 2018, projected to reach $6.8 billion by 2026
  • Sigma Labs’ breakthrough quality-assurance solution PrintRite3D® set to revolutionize 3D-printing industry, enabling it to grow globally

Sigma Labs Inc. (NASDAQ: SGLB) is set to exploit the tremendous aerospace 3D-printing-market growth potential with its revolutionary in-process, quality-assurance technology. This technology is poised to help the industry scale a critical hurdle: ensuring effective and efficient quality in real time.

The global aerospace 3D-printing market was estimated at $1.4 billion in 2018, projected to reach $6.8 billion by 2026 with an expected CAGR in excess of 22% during the forecast period. The airline and spacecraft segment is expected to lead the aerospace 3D-printing market due to the need for low-volume, low-weight parts that can be manufactured using 3D-printing technologies, which reduces supply chain constraints, minimizes warehouse space and lowers waste materials compared to traditional manufacturing processes (http://ibn.fm/cWh1C).

As the industry is challenged by environmental restrictions, high manufacturing cost and a competitive market environment, 3D metal components manufacturing offers a unique solution to help overcome much of these challenges.

Weight is considered the most important feature in the design and development of an aircraft because of its tremendous impact on fuel consumption. 3D-printing technology can help build lighter fuel-saving aircraft parts, a characteristic essential in an industry that operates at low-profit margins. Additive manufacturing provides advanced manufacturing techniques for developing the components, parts while maintaining the strength and aerodynamic features of an aircraft. This is an important motivating factor for airlines to procure newer generation aircraft, which will drive the growth of the additive-manufacturing sector. The aircraft segment currently holds the major share in 3D printing for the aerospace and defense market.

3D-printing technology also provides companies with a critical competitive advantage as it offers the flexibility to design and test products multiple times and quickly build prototypes, helping companies to cost effectively reduce uncertainties and improve the functionality of their products, thereby accelerating design cycles and reducing time to market.

By making the production process of components faster, cheaper, and simpler, while also enabling the seamless integration of components into a single structure and reducing the need for external joints, fasteners and adhesives, additive manufacturing has attracted interest from major aircraft manufacturers such as Boeing and Airbus B.V. as well as component producers such as Rolls-Royce, Pratt & Whitney and GE Aviation.

However, 3D-printing technology is facing a significant technical hurdle: real-time process monitoring and control. Due to variability in the 3D-printing process, consistent quality of produced parts is not reliably achieved without postproduction inspection, which is time consuming, costly and results in high rejection costs. Since components and parts can currently be inspected only by CT scans and other means, the producer doesn’t know until the end of the process if the finished parts meet design specifications, resulting in lost time and profits as well as the inability to economically scale up production.

Sigma Labs is revolutionizing the traditional quality assurance process with its quality-assurance software that operates in real-time, in process as parts are being formed unlike any other quality-assurance software on the market, Sigma Labs’ PrintRite3D® is a unique third-party validated software that enables real-time monitoring, analysis, feedback and control during the 3D-printing process of precision metal parts. PrintRite3D detects defects during the production process while providing feedback to machine operators allowing corrective actions to be taken , leading to faster production of metal parts with fewer errors and a more uniform product. Users will realize results in decreased downtime and waste while increasing yield and profits for 3D-printing companies.

Compared to its competitors, Sigma Labs’ PrintRite3D provides users with a superior solution. Most other solutions do not offer features such as crucial calibration filters, raw data export, machine-learning-enabled automated anomaly detection, and 3D thermal data visualization. Within the rapidly growing aerospace sector, Sigma Labs has been recognized as a superior solution to the industry’s critical needs and, as such, was selected by the industry-leading producer Airbus earlier this year to deploy its PrintRite3D Rapid Test and Evaluation Program.

With tier-1 clients such as Airbus, Siemens, Pratt & Whitney and Honeywell evaluating the software, Sigma Labs is on a clear path to break-even operations in 2020. The company is uniquely positioned to capture a significant part of the sizable addressable market with its proprietary technology that enables the entire 3D-metal-printing industry to overcome the single most-significant barrier to adoption in serial production.

For more information, visit the company’s website at www.SigmaLabsInc.com

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://ibn.fm/SGLB

SinglePoint Inc. (SING) Finalizes Distribution Agreement, Debuts Premium Tobacco Product at World’s Largest Gathering of Cannabis Professionals

  • SING announces distribution agreement with JTI USA designed to grow market for PrimeTime Little Cigars
  • SinglePoint debuts, takes orders for Little Cigars at preeminent marijuana business conference
  • Global cigar market is currently $10 billion and forecasted to grow at a CAGR of 4.23% from 2019 to 2024

SinglePoint Inc. (OTCQB: SING), a company that specializes in acquisitions of small to mid-sized companies with an emphasis in new technologies, announced that it has inked a new distribution agreement with JTI USA that could significantly grow the footprint of PrimeTime™ Little Cigars throughout North America (http://ibn.fm/Xv3cF).

“I’m excited and honored to be working with JTI to distribute PrimeTime Little Cigars,” SinglePoint CEO Greg Lambrecht stated in a news release. “The opportunity to work with a global leader in this category is exciting, and we are ready to expand Primetime’s U.S. market share with our unique experience in alternative markets. Having placed premium cigars in over 30,000 accounts, we expect this opportunity to be one of our major revenue sources in coming years, and to distribute additional JTI products as we grow this category.”

Shortly after announcing the distribution agreement, SinglePoint took its first step in its new distribution role, debuting the PrimeTime Little Cigars at the 2019 MJBIZCON show, held last week in Las Vegas. At the show, SING showcased PrimeTime Little Cigars and took its first orders for the product. SING expects the exposure gained and orders taken at the show will lead to additional distribution and alternative-market possibilities.

“We are excited to be working with SinglePoint,” added Renee Duszynski, director of sales for JTI. “SinglePoint CEO Mr. Lambrecht’s prior experience in distribution of premium cigars, we believe, will lead to continued growth of JTI USA products and the PrimeTime brand.”

Part of the JT Group of companies, JTI USA is a multibillion-dollar organization with international presence in 130 countries. As a distributor for JTI, SinglePoint will play an important part as it supports JTI’s efforts to grow the distribution and sales of PrimeTime Little Cigars. According to Mordor Intelligence, the global cigar market is currently $10 billion and forecasted to grow at a CAGR of 4.23% from 2019 to 2024.

Recognized as the best-flavored little cigars on the market, PrimeTime Little Cigars are available in cherry, grape, vanilla, and peach. This high-quality tobacco product line provides a valuable alternative for cost-conscious adult smokers who are looking for quality products.

Founded in 2011, SinglePoint invests in and acquires brands and companies that will benefit from injection of growth capital and its sales and marketing expertise. The company portfolio currently includes solar renewables, hemp and distribution tobacco products. SinglePoint is working to grow to a multinational brand.

For more information, visit the company’s website at www.SinglePoint.com

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://ibn.fm/SING

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Patented DehydraTECH™ Platform Increases CBD Tissue Absorption by 1,937%

  • DehydraTECH™ drug delivery platform achieved a 319% higher CBD blood concentration level at 60 minutes than the generic coconut oil formulation
  • The technology can be used on the nicotine market, the pharmaceutical market, and the cannabinoid market
  • No other company in the world has a patent for improved delivery of all non-psychoactive cannabinoids
  • Partnership with one of the world’s largest tobacco companies with up to $12 million in Lexaria funding for clinical investigations and product development

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has launched a revolutionary technology that accelerates intestinal absorption of bioactive substances administered without the need for inhalational dosing, co-administration with sweeteners or sugars, and other unhealthy practices. It is applicable to absorption of cannabis and nicotine, among other bioactive substances.

According to company data, DehydraTECH™ can be used successfully in multiple industries, including the nicotine market (estimated at approximately $746 billion), the pharmaceutical market (more than $68 billion), as well as the cannabinoid market (estimated at over $10.5 billion) (http://ibn.fm/NpNF4).

DehydraTECH™ is patented for all non-psychoactive cannabinoids as well as for tetrahydrocannabinol (THC) and psychoactive cannabinoids. The platform reduces the time of onset of THC by four times on average (http://ibn.fm/NzcIR).

Lexaria is the only company in the world that holds patents for oral delivery of all cannabinoids and nicotine. The company has been awarded 16 patents in the United States and Australia and holds 60 globally pending patents. Recently, Lexaria obtained two patents for treating certain conditions including, but not limited to heart disease, neurological diseases such as Alzheimer’s, Parkinson’s, schizophrenia, and others. The platform has potential applications to treat the common form of dementia as well as other nervous system diseases.

The company has developed its technology based on recognition of the fact that inhalation of drugs into the lungs can be dangerous. Edible ingestion enables much healthier and safer absorption. The platform has also been proven to deliver up to 10 times more of active ingredients than traditional edibles. DehydraTECH™ is the first platform that makes it possible to avail many of the benefits of inhalation while greatly reducing the risks.

Medical researchers have struggled to find ways to penetrate the blood brain barrier effectively to transport beneficial drugs for many years. This barrier exists to block toxic or otherwise dangerous substances from entering the brain and is formed by layers of microvascular endothelial cells inside blood vessels. Lexaria’s DehydraTECH™ drug delivery platform brings beneficial drugs to the brain faster.

In June 2019, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH™ technology. This series built on the company’s original, independent, third-party laboratory in vitro lab experiments began in 2015, which showed utilization of the DehydraTECH™ drug delivery platform increased the absorption levels of cannabidiol (CBD) in human intestinal cells by an impressive 499%. The results of the studies showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH™ technology in comparison with generic industry MCT coconut-oil formulations. Moreover, the animal studies using the enhanced formulation showed an 811% increase of CBD delivery into the blood in comparison with generic MCT coconut-oil formulations.

Additionally, Lexaria recently partnered with one of the world’s largest tobacco companies, which is providing up to $12 million to fund 100% of Lexaria’s portion of the obligations for clinical investigations and development of oral forms of nicotine delivery using the DehydraTECH™ drug delivery platform (http://ibn.fm/JZBKX).

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Focuses on Growing the Leading Cannabis Gummy Brand in California, Announces New Distribution Partner

  • Plus Products boasts best-selling cannabis product in California in 2019
  • Company recently announced transition to HERBL Distribution Solutions as main California distribution partner
  • PLUS is growing brand, focusing on both current and new market opportunities

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF), a hemp and cannabis food company using nature to bring balance to consumers’ lives, is on a mission to make cannabis safe and approachable. PLUS(TM) is working to build the world’ strongest cannabis brand. Headquartered in San Mateo, California, the company focuses on producing edibles using extracts to ensure compliant, dosable and appetizing products that provide a consistent cannabis experience.

PLUS’s products are ranked as one of the top edibles brands in the state of California, which is the largest legal cannabis market in the United States. The company has the state’s best-selling cannabis product, as well as the best-selling gummies brand in California. At present, PLUS products are available in 360 licensed retailers in the state, and PLUS has sold more than 2.5 million branded units since January 1, 2018 (http://ibn.fm/wtvy4).

Recently, Plus Products announced its transition to HERBL Distribution Solutions as its chief California distribution partner, along with the termination of its distribution relationship with Calyx Brands Inc. HERBL is a leader in the California marketplace with active distribution to more than 600 licensed retailers across the state. PLUS’ internal sales team is working directly with HERBL’s team to facilitate a speedy and efficient transition for PLUS’ current retail partners and to open new accounts moving ahead (http://ibn.fm/wn37D).

“After an extensive review of the major California cannabis distributors, we determined that HERBL was best positioned to scale with PLUS and reliably deliver product to retailers at the lowest cost,” PLUS co-founder and CEO Jake Heimark stated in a news release. “Their substantial market reach and world-class management team give us confidence that they will help PLUS further solidify our position as the largest cannabis-infused gummies brand in California.”

In California, PLUS has established its iconic product: PLUS Gummies (cannabis infused). Its Plus Uplift Sour Watermelon was the best-selling cannabis product in California in 2019.

Of note to investors is that Plus Products is centered on quality growth in California and beyond. Its emphasis is on thoughtfully building a brand in a strategic, deliberate approach. The company is growing its brand through new markets, new products and new consumers.

Plus Products continues to be driven by its dedication to premier dosable products. For investors, PLUS is marketing creatively including product launch partnerships with American Superstar John Legend and direct-to-consumer sleep pioneer Casper. PLUS recently entered the National Hemp CBD market expected to exceed $20 billion by 2022.

For more information, visit the company’s website at www.PlusProducts.com

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://ibn.fm/PLPRF

Sharing Services Global Corporation (SHRG) Continues to Post Record Sales; Forecasts Continued Success Moving into New Year

  • SHRG posts record Q2 revenues, cumulative sales of $169 million since launching proprietary line of products.
  • CEO says record sales demonstrate that SHRG sales, support strategies are on the right path.
  • Company officials believe SHRG will be able to fund working capital needs for the next year with existing cash and cash equivalents with cash provided through operations and secured and unsecured debt, including through issuance of convertible notes and short-term borrowings under financing arrangements and occasional capital transactions

In its most recent SEC filing, Sharing Services Global Corporation (OTCQB: SHRG), a diversified holdings company in the direct-selling industry, posted record Q2 revenues and cumulative sales of $169 million since the company launched its own proprietary line of products (http://ibn.fm/fqmLo). Specifically, the company reported record-breaking revenues of $38.9 million for its fiscal quarter ended October 31, 2019, more than double the $18 million revenues reported in the comparable quarter of fiscal 2019.

“Product sales for our incredible health and wellness products of Elevacity Global continue to be strong, consistently increasing each quarter,” SHRG CEO John “JT” Thatch stated in a news release. “Our Q2 revenues demonstrate that our sales and support strategies are on the right path as we continue to grow in the direct selling marketplace. We attribute our success to our independent distributors, which we refer to as Elepreneurs, and our incredible team at the corporate offices.”

SHRG’s financial numbers were reported in its most recent quarterly report filed with the Securities and Exchange Commission (http://ibn.fm/ZAbhv), which noted that “the accompanying consolidated financial statements have been prepared on a going concern basis, which assumes the company will be able to realize its assets and settle its liabilities in the ordinary course of its business for the foreseeable future.”

Noting that the company is an emerging growth company and, prior to its fiscal quarter ended January 31, 2018, it had virtually no sales, the filing then reported that SHRG’s “quarterly net sales have increased, and gross margin has expanded each quarter since the December 2017 launch of its Elevate health and wellness product line. For the full fiscal year ended April 30, 2019, cash provided by operations was $6.0 million on annual sales of $85.9 million. In addition, for the six months ended October 31, 2019, cash provided by operations was $12.1 million on sales of $74.3 million, while operating earnings were $3.9 million. As of October 31, 2019, cash and cash equivalents were $12.8 million.”

In the filing, company officials reported that they believe SHRG will be able to fund working capital needs for the next year with existing cash and cash equivalents, with cash provided through operations and secured and unsecured debt, including through the issuance of convertible notes and short-term borrowings under financing arrangements and capital transactions from time to time. “The company believes there is no longer reasonable doubt as to [its] ability to continue as a going concern in the foreseeable future,” the filing noted.

“SHRG will continue its efforts to expand revenues through its subsidiaries by added support, expansion efforts and by bringing on additional experienced industry talent to help these efforts on a large scale,” Thatch stated in a news release. “The company will continue to evaluate its expansion plans, products and strategies to continue its success as we enter into 2020.”

Sharing Services Global Corporation is a diversified company, with Elepreneurs Holdings and Elevacity Holdings being its primary operating subsidiaries. SHRG markets and distributes health and wellness products that are sold under the Elevate brand through an independent sales force of distributors, or Elepreneurs, using the direct-selling business model. Sharing Service’s current product offerings include its Elevate health and wellness product line, launched in December 2017. The company’s Elevate product line consists of nutraceutical products referred to as D.O.S.E., which refers to the key hormones dopamine, oxytocin, serotonin, and endorphins.

Sharing Services is dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies in the direct-selling industry. The Sharing Services combined platform leverages the capabilities and expertise of various companies that market and sell products direct to the consumer through independent contractors.

For more information, visit the company’s website at www.SHRGInc.com

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

MCTC Holdings Inc. (MCTC) CEO Discusses Development of Hemp-Related Products and Delivery Technologies in Exclusive Interview

  • The company aims to promote cannabinoid-infused beverages without adverse side effects, superior to most analogical products, to potentially replace alcohol
  • Expanding on development of infusion technologies to include exotic cannabinoids, such as CBN and THC-V, which may improve sleep and control appetite
  • Global industrial hemp market is expected to grow to $26.6 billion by 2025 at CAGR of 34.0%

Cannabinoid science innovator MCTC Holdings Inc. (OTC: MCTC), doing business as Cannabis Global, Inc., is undergoing a rebranding process with the goal of developing unique products that will allow it to take advantage of cannabis industry opportunities while avoiding overcrowded and potentially problematic niches like retail and cultivation, according to CEO and Chairman Arman Tabatabaei in an exclusive interview with NetworkNewsWire (http://ibn.fm/7O6d5).

Ever since the company’s reorganization in June 2019, its rebranding has focused on developing unique cannabis-related intellectual properties, products, and technologies (http://ibn.fm/lXQlz). According to its CEO, the company is targeting the middle part of the market, specifically the post-processing of refined hemp products. MCTC aims to process refined products such as hemp isolates and distillates using special delivery systems, on which the company has filed patents, and sell them through food, beverage and consumer brands.

One of the company’s revolutionary brands is “Hemp You Can Feel™,” based on an alcohol beverage replacement technology that is unique in the way it is delivered to the body. When consuming hemp extract conventionally, people tend not to feel the effects at once and aren’t motivated to keep taking it. With Hemp You Can Feel™, the consumer enjoys a relaxed sensation with none of the downsides of alcohol consumption. “Probably the most remarkable feat we have accomplished in the laboratory is that while the products are based on hemp extracts, the levels are so low that they are undetectable in industry tests,” Tabatabaei said in the interview.

The company has filed a patent on this delivery technology, which covers aspects of nanoparticles and nanofibers comprising one or more cannabinoids disposed within a water-soluble medium. Using this method, the substance is delivered to the body in small amounts and maximally absorbed as a result. What is more, the development of novel polymeric nanofibers and nanoparticles will allow for potentially adjustment of cannabinoid combinations, extremely high loading rates, controlled release parameters, and precise dosing all at the same time.

Through 2020, the company plans to conduct trials on exotic and lesser-known cannabinoids like cannabinol (CBN) and tetrahydrocannabivarin (THC-V), including their potential effects on sleep and appetite suppression. There is currently very little research into these two cannabinoids, Tabatabaei said. “We don’t want to divulge too much about the research direction, but we’re going to be producing some delivery systems that we think will be extremely innovative. A lot of research needs to be done in these areas,” he added.

MCTC Holdings is a Delaware registered, fully reporting and audited publicly traded company. With the hemp industry moving very quickly and with a growing number of market entrants, MCTC plans to concentrate its efforts on the middle portions of the hemp value chain. The company plans to actively pursue R&D programs and productization for exotic extract isolation, bioenhancement of hemp extracts and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The company was reorganized during June of 2019 and announced its intent to enter the fast-growing hemp sector. The company is headed and managed by a group of highly experienced hemp and cannabis industry pioneers and entrepreneurs.

The company is focused on multiple growing verticals within the global cannabis and CBD industry. Through strategic partnerships, acquisitions, and the development of intellectual property, MCTC seeks to position itself as a leading provider of innovative and unique hemp-related products and technologies on the fast-growing global industrial hemp market, projected to reach $26.6 billion by 2025 from 4.6 billion in 2019, expanding at a CAGR of 34 percent (http://ibn.fm/A3xjj).

For more information, visit the company’s website at www.CannabisGlobalInc.com

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://ibn.fm/MCTC

5 Key Questions to Ask When Looking for a Short-Term Rental Insurance Policy

  • Global vacation rental market is predicted to reach $63 billion in five years
  • InsuraGuest’s InsurTech platform covers a wide range of liablities, including accidental damage to rooms, lost or stolen items, medical expenses, death or dismemberment
  • Platform has potential to access millions of properties worldwide

Unforeseen events can be costly for any vacation rental property owner. From property damage to stolen goods and more, there are many issues that can affect both the property owner or host and the guests of a vacation rental.

Sadly, there isn’t much that can be done to resolve these issues once they have become fact. The only solution is to ensure that the property is under adequate protection via a specialized insurance policy. And given that traditional insurance doesn’t typically cover a wide range of events that can affect a vacation rental property, owners need to look towards short-term rental insurance policies. Here are 5 questions to ask when looking for a short-term rental insurance policy to ensure you are getting the best possible coverage.

  1. Why Should I Get a Short-Term Rental Insurance Policy?

This is the obvious first question. Short-term rental insurance is often cheaper than commercial or landlord property insurance and specifically tailored to cover short-term rental needs. A homeowner’s policy rarely provides full coverage, meaning additional protection is necessary. Few things can feel as disheartening as renting to earn a bit of money, then have to spend it on getting your belongings repaired or replaced.

Service-as-a-software (SaaS) company InsuraGuest Inc.’s Guest Protection Policy, sold to hotels and vacation rental properties through its proprietary InsurTech software platform, and extended to the guest from the time of check-in to check-out. It covers a wide range of liabilities, such as accidental damage to rooms, lost or stolen items, medical expenses, death or dismemberment.

InsuraGuest is complimentary to your current Homeowners and or General Liability insurance coverage. It becomes the first line of defense for the guest, which results in the first line of defense for the property.

  1. How Much Will It Cost?

To figure out how much the short-term rental insurance policy will end up costing you, consider the cost of premiums (your monthly, biannual, or annual payment), the amount of liability coverage or coverage for damaged property, and your deductible. Your deductible is the amount you’ll have to pay before the insurance provider pays for a claim.

  1. What Does the Policy Cover?

Liability coverage covers medical costs incurred if your guests are injured on your property. Vacation rental insurance reduces the cost of repair and replacement and recovers losses due to theft or damage to your personal property and belongings. Homeowners insurance won’t cover damages to the guests or to the property when it is being rented out.

  1. Am I Choosing the Best Company?

To make sure you’re getting the best provider, ask whether they offer the specific type of coverage you need and how long they have been on the market. You need to be sure the provider is financially stable enough to cover a claim. Another thing to look for is good reviews from existing customers. It’s important to be able to get in touch with an agent or customer service easily if you have any questions. You should also ask whether you might qualify for any discounts, or who is going to pay for the coverage. With companies like InsuraGuest, the premium payment is a pass through for the property to the guest at the time of check-in.

  1. How Do I Get the Right Coverage and Quotes?

How much coverage is enough? It’s a good idea to consult a professional, ideally an independent agent. That way you know what the rules for your state are and you’re getting the most current and accurate information. You need adequate coverage before you start receiving guests, even if you decide to buy a policy for home-sharing rentals.

Facts About the Vacation Rental Industry

The global vacation rental market is expanding rapidly, being projected to reach nearly $63 billion from 2020 to 2024, with a year-over-year growth rate for 2020 estimated at 5.51%. In 2019, vacation rental revenues are expected to reach $57.669 billion, from an estimated 297.17 million total vacation rental users worldwide. The entire vacation rental market is expected to topple the hotel industry by 2020 (http://ibn.fm/tHw46).

InsuraGuest has outstanding prospects on the global market, intending to expand the scope of its InsurTech platform and insurance products to cover European Union member states and the United Kingdom, as well as Asia before mid-2020. The company currently provides coast-to-coast coverage in the U.S.

With the U.S. accounting for 20 percent of all vacation rental properties and Europe accounting for 60 percent, and Europe, Asia and the U.S. having a combined 6.5 billion hotel nights stayed, InsuraGuest will have access to a massive demographic and more than double its vacation rental opportunities. With the ability to easily integrate with most properties’ management systems, the InsurTech platform has the potential to access millions of properties worldwide.

For more information, visit the company’s website at www.InsuraGuest.com

NOTE TO INVESTORS: The latest news and updates relating to InsuraGuest are available in the company’s newsroom at http://ibn.fm/InsuraGuest

SRAX Inc.’s (NASDAQ: SRAX) BIGtoken Mobile App Collects Accurate Information, Allows Users to Unlock Value of Data

  • SRAX’s BIGtoken platform allows consumers to own, monetize their data
  • BIGtoken mobile app conducts surveys that gather valuable information
  • Recently, BIGtoken surveyed more than 25,000 Americans about political issues, revealing relevant issues in upcoming presidential election

SRAX Inc. (NASDAQ: SRAX) uses its BIGtoken app to help consumers both own and get paid for their data. While major companies such as Snapchat, Facebook and Twitter make enormous amounts of money through data collection and advertisements, consumers do not receive any compensation for providing that data. Moreover, in recent years, concerns have been growing over data privacy. SRAX is evening the playing field by allowing consumers to both privatize and monetize their data.

BIGtoken’s innovative approach to data collection has led to the completion of valuable and high-quality surveys. The platform currently has more than 16 million users worldwide (http://ibn.fm/7Y3sO). These engaged consumers can feel safe providing accurate information, knowing that the data is anonymized before access to it is sold. SRAX is providing a unique experience, as this consumer control is unprecedented among large social media platforms and data brokers that sell people’s personal data to a number of interested buyers without anonymizing that data.

SRAX recently released a survey that contained revealing information about political issues that is highly relevant in the upcoming presidential election. More than 25,450 Americans took the survey on the BIGtoken mobile app. Survey results provided several insightful takeaways.

In this survey, 59% of respondents – the majority being women – said that President Donald Trump should be impeached. The survey also showed that important topics for women in particular in the upcoming election include health care costs (76%), universal health care (70%), student loans (67%) and immigration (63%). Interestingly, the survey also showed that half of women are unconcerned by the gender gap, and only 19% of the women surveyed felt that there were too few women in government.

These kinds of surveys provide invaluable information. Using the BIGtoken app, everyone, including consumers, benefit from the collected data. SRAX COO Kristoffer Nelson believes that “it’s critical to keep an eye on changing attitudes, and platforms like BIGtoken provide an ideal mechanism for brands and businesses to measure the pulse of today’s consumers.”

After downloading the BIGtoken app, a person can immediately start earning rewards by taking surveys, answering quick consumer questions and more. This information is then sold to advertisers and media companies so that they can use transparent, verified consumer data to improve their marketing approaches. SRAX is working toward creating the most valuable opted-in data set in the world.

For more information, visit the company’s website at www.SRAX.com

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

From Our Blog

SuperCom Ltd. (NASDAQ: SPCB) Further Expands U.S. Footprint with North Carolina Electronic Monitoring Contract

December 29, 2025

SuperCom (NASDAQ: SPCB), a global provider of secured e-Government, IoT, and cybersecurity solutions, continues to broaden its presence in the U.S. electronic monitoring (“EM”) market, announcing a new service provider partnership in North Carolina that extends its reach to a 15th new state entered since mid-2024. The agreement marks SuperCom’s first deployment in North Carolina […]

Rotate your device 90° to view site.